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Background: In lung cancer, an association between tobacco smoking and promoter DNA hypermethylation has
been demonstrated for several genes. However, underlying mechanisms for promoter hypermethylation in
tobacco-induced cancer are yet to be fully established.
Methods: Promoter methylation was evaluated in control and cigarette smoke condensate (CSC) exposed
human lung cells using the Methyl-Profiler DNA Methylation PCR System. PSAE cells were exposed to 0.3 or
1.0 μg/ml CSC for 72 hours and longer term for 14 and 30 days. NL-20 cells were exposed for 30 days to 10
or 100 μg/ml CSC.
Results: Promoters of several genes, including hsa-let-7a-3, CHD1, CXCL12, PAX5, RASSF2, and TCF21, were
highly methylated (>90%); hsa-let-7a-3 was affected in both cell lines and under all exposure conditions. Level
of methylation tended to increase with CSC concentration and exposure duration (statistical differences were
not determined). Percentage methylation of TCF21, which was >98% at exposures of 10 or 100 μg/ml CSC,
was found to be reduced to 28% and 42%, respectively, in the presence of the dietary agent genistein.
Conclusions: Using array techniques, several tumor suppressor genes in human lung cells were identified
that undergo promoter hypermethylation, providing further evidence of their potential involvement in
tobacco smoke-induced lung carcinogenesis and their use as potential biomarkers of harm in tobacco smoke
exposure. Results from the study also demonstrated the potential of a dietary agent to exert chemopreventive
activity in human tissue against tobacco smoke related diseases through modulation of DNA methylation.
Additional studies are needed to confirm these findings.
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Epidemiological studies indicate that cigarette smoking
has a strong association with lung cancer [1,2]. Approxi-
mately 80-90% of lung cancers are attributable to cigarette
smoking [3]. Elucidation of the underlying mechanisms of
smoke-induced lung carcinogenesis can help define future
strategies for early diagnosis, prognosis, treatment, and
prevention of lung cancer [4] and inform the regulation of
tobacco products.
In cancer biology, the best understood epigenetic mech-
anism refers to DNA hypermethylation of specific loci
(CpG islands) in the promoter region of known and pre-
sumptive tumor suppressor genes, which is a hallmark of* Correspondence: ghammons@nctr.fda.gov
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unless otherwise stated.human tumors, in general [5], and of lung cancer, in par-
ticular [6,7]. In lung cancer, promoter DNA methylation
that leads to gene silencing is a common event, with a
large number of aberrantly methylated genes having been
identified [6-10]. Furthermore, methylation has been de-
scribed as an early event in lung tumorigenesis [7]. Cur-
rently, DNA methylation appears as one of the most
promising epigenetic biomarkers, which can improve the
early detection of cancer and subsequent management of
patients with diagnosed malignancy.
A positive correlation between tobacco smoking and
promoter hypermethylation in human lung cancer tissue
has been demonstrated for several genes (reviewed in
[11]). However, the underlying mechanisms for promoter
hypermethylation in tobacco-induced cancer are yet to
be fully established. In this study, array techniques wereral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cancer-focused panel of genes in two noncancerous hu-
man lung cell lines exposed to cigarette smoke conden-
sate (CSC) both short-term and longer term, in order to
identify genes whose methylation status can be affected
by CSC exposure, which can provide increased insight
into potential molecular mechanisms and biological
pathways behind the development and progression of
this tobacco-related disease as well as assisting in discov-
ering biomarkers useful for its detection and monitoring.
Materials and methods
Cell lines and treatment conditions
The human lung cell lines, PSAE (primary small airway
epithelial) cells (PCS-301-0100), NL-20 (immortalized
bronchial epithelial) cells, A549 (adenocarcinomic alveolar
basal epithelial) cells and H1299 (non-small lung carcin-
oma) cells, were obtained from the American Type Culture
Collection (ATCC) (Manassa, VA). The cells were cultured
in growth medium as recommended by the supplier.
Cigarette Smoke Condensate (CSC) was purchased (Murty
Pharmaceuticals; Lexington, KY), which was prepared
from Kentucky standard cigarettes (1R3F; University of
Kentucky, Lexington, KY) using a smoking machine de-
signed for Federal Trade Commission testing. For smoke
condensate exposure experiments, cells (400,000 cells per
plate) were cultured with or without CSC (in DMSO; final
vol., 0.1%) for 72 hrs. Longer term exposures were for 14
and 30 days. Medium was changed every three days with
new CSC for the longer term studies. At appropriate
times, cells were harvested, and processed for further
analysis. In experiments with genistein (Sigma-Aldrich;
St. Louis, MO), the agent was also added to cell cultures
exposed to CSC.
DNA isolation and DNA methylation PCR array
Genomic DNA was extracted from cells using the
QIAMP DNA Mini Kit (Qiagen Inc.; Valencia, CA) ac-
cording to the manufacturer’s instructions. The methyla-
tion status of selected genes was evaluated using the
Methyl-Profiler DNA Methylation PCR Array: Human
Lung Cancer EpiTect Methylation Signature Panel
MeAH-041 (SABioscience, Qiagen; Frederick, MD). As
noted by the manufacturer, the Panel profiles the methy-
lation status of 24 tumor suppression gene promoters
whose hypermethylation has been reported in the lit-
erature the most frequently in a variety of lung tumors.
Using 1.0 μg of total DNA, the analysis was conducted
according to the manufacturer’s protocol. PCR was
run in the iQ5 Realtime Detection System (Bio-Rad;
Hercules, CA). Quantification of relative mRNA levels
was carried out by determining the threshold cycle
(CT). Cycles were programmed as specified in the Methyl-
Profiler protocol.Methylation data analysis
The Methyl-Profiler PCR Array Excel-based data ana-
lysis template was downloaded from the SABioscience
website at: http://www.sabiosciences.com/dna_methyla-
tion_analysis.php. CT values were entered into the raw
data table and results were automatically determined
by the template through a series of mathematical equa-
tions for each gene analyzed. These equations and cal-
culations are described in detail in the Methyl-Profiler
DNA Methylation PCR Array System User Manual
(SABioscience, Qiagen). Percent methylation was cal-
culated by these equations using the appropriate CT
values. Heatmap analysis was performed using R stat-
istical software (http://r-project.org).
Results and discussion
In the present study, the degree of promoter methylation
across a defined panel of genes was evaluated in control
and CSC exposed cells using the Methyl-Profiler DNA
Methylation PCR System technology. The signature
panel was chosen based on representation of genes that
have been reported to be altered in a variety of lung can-
cers. PSAE cells were exposed to 0.3 or 1.0 μg/ml CSC
for 72 hours and longer term for 14 and 30 days. Com-
pared to controls (DMSO only) at these time points
eight of the twenty-four genes in the panel were identi-
fied that displayed an increased percentage of promoter
methylation after exposure to 1.0 μg/ml CSC for 14 or
30 days. The genes included CDH13, CDKN2A, CDKN2B,
CYP1B1, MGMT, RASSF1, and SFRP1 (Figure 1). Percent-
age methylation ranged from 19% to 53%. Increased
methylation of RASSF1 and SFRP1 was also observed after
exposure to 0.3 μg/ml CSC for 30 days. One gene, hsa-let-
7a-3, was highly methylated (>90%) under all of the ex-
posure conditions (Figure 1). NL-20 cells were exposed
for 30 days at concentrations of 10 and 100 μg/ml CSC.
At both concentrations promoters of six genes, hsa-let-
7a-3, CHD1, CXCL12, PAX5, RASSF2, and TCF21, were
identified as being highly methylated (>97%) (Figure 2).
The percentage of methylation in four other genes,
CADM1, CDKN1C, CYP1B1, and OCPML, increased with
CSC concentration (Figure 2).
The gene affected in both cell lines and under all of the
exposure conditions was hsa-let-7a-3. Let-7s are a family
of highly conserved archetypical miRNAs, containing 13
members located on nine different chromosomes. Much
of the available evidence supports hsa-let-7a as a lung can-
cer related tumor suppressor (as reviewed in [12,13]). Sev-
eral cellular protein targets of hsa-let-7a have been
identified, such as c-MYC, HMGA, STAT3, NIRF, RAS.
Over-expression of let-7a was shown to be related to in-
creases in overall survivals of NSCLC patients. Hsa-let-7
is also a prognostic factor indicating the prevention
of recurrence in surgically resected NSCLC patients.
Figure 1 Heatmap of the intensity of promoter methylation of the 24-genes panel in PSAE (human primary small airway epithelial)
cells. Cells were cultured in the absence or presence of 0.3 or 1.0 μg/ml CSC for 3, 14 or 30 days. Methylation was assessed by the Methyl-Profiler
DNA Methylation PCR System. Methylation analysis in the lung cancer lines, A549 and H1299, is also represented. Color code and intensity indicate
level of methylation.
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lung cancers. Furthermore, lung cancer patients with re-
duced hsa-let-7a expression were found to have signifi-
cantly worse prognosis. Hsa-let-7a inhibits growth of lung
cancer cells in vitro. Decreased let-7a-3 expression has
also been demonstrated in breast cancer [14]. Two other
studies, however, suggest that miRNA let-7a-3 may behave
in favor of tumor progression [15,16]. The reasons for
these contrasting results are not clear. Cigarette smoke
typically induces let-7a down-regulation, as demonstrated
in animal studies. miRNA let-7 has been shown to be
down-regulated in the lungs of rat exposed to environ-
mental tobacco [17], as well as in mouse lungs [18]. Al-
though results from several studies have also shown that
DNA methylation may be involved in the regulation oflet-7a-3 [14-16], there have been no previous reports of
promoter methylation of this gene in response to tobacco
smoke exposure.
The ability of the dietary agent genistein to modulate
CSC-induced promoter methylation was also explored.
Increasing evidence indicates that an important pathway
in the chemopreventive activities of dietary components
is their ability to regulate the epigenome [19]. Genistein,
one of the soy-derived bioactive isoflavones, modulates
DNA methylation. For example, genistein was found to
decrease methylation of BRCA1, GSTP1, and EPHB2 pro-
moters in prostate cancer cell lines [20]. In the present
study, NL-20 cells were exposed to CSC in the presence of
genistein (10 μM). Promoter methylation was assessed
in the twenty-four genes panel. Under the conditions
Figure 2 Heatmap of the intensity of promoter methylation of the 24-genes panel in NL-20 (human immortalized bronchial epithelial) cells.
Cells were cultured in the absence or presence of 10 or 100 μg/ml CSC for 30 days. Methylation was assessed by the Methyl-Profiler DNA Methylation













Figure 3 Effect of genistein on CSC-induced methylation. NL-20 cells were exposed to 10 or 100 μg/ml CSC for 30 days in the presence of 10 μM
genistein. Cells were also treated with genistein in the absence of CSC. Methylation was assessed by the Methyl-Profiler DNA Methylation PCR System.
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was >98% at exposures of 10 or 100 μg/ml CSC, was re-
duced to 28% and 42%, respectively, in the presence of ge-
nistein (Figure 3). The level of methylation in other genes
was not altered. The transcription factor TCF21 is widely
expressed; its normal function is to promote mesenchymal
transition into epithelial cells [21]. It has been identified as
a tumor suppressor gene [22]. TCF21 is reported to be fre-
quently hypermethylated and silenced in head and neck
and lung cancers, and restoration of TCF21 expression
inhibited tumor growth, both in a lung cancer cell line
and in a mouse xenograft model [22]. The results found in
our study add support that up-regulation of hypermethy-
lated tumor suppressor genes may be a potential path-
way for chemoprevention in tobacco smoke-induced lung
cancer and that the methylation status of the tumor sup-
pressor gene TCF21 may be an important biomarker for
monitoring the chemopreventive activity.
Several limitations of this study are noted. CSC is
widely used in model systems to study in vitro effects of
tobacco smoke [23-26]. A disadvantage is that cell cul-
ture models often do not exhibit all the differentiated
and functional characteristics of the corresponding na-
tive epithelium or the entire organ. A concern can also be
the inherent instability, especially on long term culture.
Treatment with CSC may not exactly replicate in vivo re-
sponses to smoke exposures. However, in in vitro research,
cellular and subcellular functions can be studied with
more ease in a simplified, direct biological model system
using guidelines for good cell culture practice, which al-
lows the prediction of mechanisms that may be relevant
to in vivo situations. In the current study, two cell lines
were included to permit assessing effects at various trans-
formational stages and to meet the need to examine re-
sults in more than one cell line. The CSC dose range used,
although difficult to compare with that in human airways
in smokers, is similar to those previously reported in other
in vitro studies (0 – 125 μg/ml) [23-26]. Additionally, the
average yield of CSC was 26.1 mg/cigarette. Therefore, the
dose of 1 μg/ml is reachable if an individual with 60 kg
body weight takes only 3–4 cigarettes and all of the smoke
was absorbed [27]. It is quite possible that doses up to
100 μg/ml could be reached in the human airways of
smokers, especially concerning the accumulation of smoke
compounds over a smoker’s life [28]. The array approach
employed in the study permitted the surveying of a panel
of 24 genes that included multiple time points and con-
centrations. However, for each time-concentration point
an individual 96-well plate was required. As such, multiple
determinations were not conducted; statistical analysis
of significant differences in methylation levels could
not be included. Validation of the array data will be
needed and should be done in future studies for those
genes of interest. Despite these potential limitations,our experiments yielded several interesting and poten-
tially relevant findings.
Conclusions
This study, using the array techniques, identified several
tumor suppressor genes in human lung cells whose pro-
moter methylation was increased upon exposure to CSC,
providing further evidence of their potential involve-
ment in tobacco smoke-induced lung carcinogenesis. The
miRNA hsa-let-7a may play a critical role and provide a
potential biomarker of harm in tobacco smoke exposure,
given the observations from both cell lines included in
the study. Results from the study also demonstrated
the potential of a dietary agent to exert chemopreventive
activity in human tissue against tobacco smoke related
diseases through modulation of DNA methylation. Add-
itional studies are needed to confirm these findings, to
screen other genes and other cell lines, and to further
characterize the role and impact of epigenetic changes in
tumor suppressor genes in tobacco smoke-induced harm.
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